At-Home Colorectal Cancer Screening
Colorectal Cancer Screening
CommercialActive
Key Facts
About SNT Biotech
SNT Biotech is a private, commercial-stage diagnostics company focused on at-home screening tests to enable early detection of conditions like colorectal cancer and diabetes. Its business model centers on providing testing kits and services directly to consumers and through partnerships with health plans and providers, targeting improved preventive care metrics and reduced healthcare costs. The company emphasizes its status as a minority and women-owned business to meet supplier diversity goals. While showing commercial activity, it appears to be in an early revenue phase, leveraging a distribution platform rather than a proprietary technology platform for test development.
View full company profileTherapeutic Areas
Other Colorectal Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| Shield (ECLIPSE Study) | Guardant Health | FDA Approved |
| Urine cfDNA Test for Colon Cancer Screening | JBS Science | Development |
| iFOB | Pangea Laboratory | Commercial |
| ColoHealth | New Day Diagnostics | Approved |
| CRC Screening Program | Polymedco | Commercial |
| SimpleScreen CRC | Freenome | Commercial (as LDT) |
| ColoScape™ / QuantiDNA™ | DiaCarta | Commercial |
| ColoSense | Geneoscopy | Approved |
| FIT System & Assay Development | Sentinel Diagnostics | Commercial |
| Next-Generation Cologuard® | Exact Sciences | Development |
| ColoAlert® | Mainz Biomed | Pivotal Trial |